Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Eur J Pharm Biopharm ; 114: 154-163, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28161548

RESUMO

Melasma treatment with combined retinoic acid (RA) and hydroquinone (HQ) usually causes unsatisfactory outcomes and safety concerns. This study attempted to evaluate the cutaneous absorption and skin tolerance of the codrug conjugated with RA and HQ via ester linkage. The codrug's permeation of the pig skin was estimated using Franz diffusion cell. The codrug and parent drugs were comparatively examined for anti-inflammatory activity and tyrosinase inhibition. In vivo cutaneous irritation was assessed on nude mouse skin. Chemical conjugation of RA with HQ increased the lipophilicity and thus the skin absorption. The codrug absorption produced a 5.5- and a 60.8-fold increment compared to RA skin deposition at an equimolar (1.2mM) and saturated solubility dose, respectively. The cumulative amount of HQ derived from the codrug in the receptor was comparable to or less than that of topically applied HQ. The RA-HQ codrug was partly hydrolyzed on penetrating the skin. The hydrolysis rate in intact skin was significantly lower than that in esterase medium and skin homogenates. The codrug showed an interleukin (IL)-6 inhibition activity comparable to RA. A therapeutic index 6-fold greater than RA was obtained with the topical codrug. The tyrosinase inhibition percentage of the codrug and HQ was 13% and 21%, respectively. The skin tolerance test determined by transepidermal water loss (TEWL), redness, and histopathology had exhibited minor skin irritation caused by the codrug compared to the physical mixture of RA and HQ at an equivalent dose. Topical codrug delivery not only promoted RA absorption, but also diminished the adverse effects of the parent agents.


Assuntos
Hidroquinonas/administração & dosagem , Hidroquinonas/uso terapêutico , Melanose/tratamento farmacológico , Absorção Cutânea/efeitos dos fármacos , Tretinoína/administração & dosagem , Tretinoína/uso terapêutico , Administração Cutânea , Animais , Combinação de Medicamentos , Feminino , Hidrólise , Interleucina-6/biossíntese , Interleucina-6/genética , Irritantes , Camundongos , Camundongos Nus , Solubilidade , Suínos , Tretinoína/efeitos adversos
3.
J Chromatogr A ; 1479: 62-70, 2017 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-27988078

RESUMO

In this study, a magnetic iron oxide nanoparticle-based solid-phase extraction procedure combined with the online concentration and separation of salicylic acid (SA) through micellar electrokinetic chromatography-UV detection (MEKC-UV) was developed. Under optimal experimental conditions, a good linearity in the range of 0.01-100µmolL-1 was obtained with a coefficient of correlation of 0.9999. The detection sensitivity of the proposed method exhibited an approximately 1026-fold improvement compared with a single MEKC method without online concentration, and the detection limit (S/N=3) was 3.80nmolL-1. The repeatability of the method was evaluated using intraday and interday RSDs (11.5% and 17.0%, respectively). The method was used to determine SA concentrations in tobacco leaves (Nicotiana tabacum L. cv. Samsun) from the NN genotype, nn genotype, and Nt-NahG mutant strains, as well as in shampoo and ointment samples. Rapid extraction and separation (<50min), acceptable repeatability (RSD<17.0%), and high spiked recoveries (95.8%-102.4%) were observed for plants, detergents, and pharmaceuticals.


Assuntos
Técnicas de Química Analítica/métodos , Cromatografia Capilar Eletrocinética Micelar , Compostos Férricos/química , Nanopartículas/química , Folhas de Planta/química , Ácido Salicílico/análise , Extração em Fase Sólida , Técnicas de Química Analítica/instrumentação , Limite de Detecção , Micelas , Nicotiana/química
4.
Eur J Pharm Sci ; 92: 1-10, 2016 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-27345564

RESUMO

Use of the ablative laser has been approved to enhance topical drug penetration. Investigation into the usefulness of the non-ablative laser for assisting drug delivery is very limited. In this study, we explored the safety and efficacy of the non-ablative fractional erbium:glass (Er:glass) laser as an enhancement approach to promote drug permeation. Both pig and nude mouse skins were employed as transport barriers. We histologically examined the skin structure after laser exposure. The permeants of 5-aminolevulinic acid (ALA), imiquimod, tretinoin, peptide, dextrans and quantum dots (QD) were used to evaluate in vitro and in vivo skin passage. The fractional laser selectively created an array of photothermal dots deep into the dermis with the preservation of the stratum corneum and epidermis. The barrier function of the skin could be recovered 8-60h post-irradiation depending on the laser spot densities. The application of the laser caused no local infection of Staphylococcus aureus and Pseudomonas aeruginosa. Compared to intact skin, ALA flux was enhanced up to 1200-fold after laser exposure. The penetration enhancement level by the laser was decreased following the increase of permeant lipophilicity. The skin accumulation of tretinoin, an extremely lipophilic drug, showed only a 2-fold elevation by laser irradiation. The laser promoted peptide penetration 10-fold compared to the control skin. Skin delivery of dextrans with a molecular weight (MW) of at least 40kDa could be achieved with the Er:glass laser. QD with a diameter of 20nm penetrated into the skin with the assistance of the non-ablative laser. The confocal microscopic images indicated the perpendicular and lateral diffusions of dextrans and nanoparticles via laser-created microscopic thermal zones. Controlled Er:glass laser irradiation offers a valid enhancement strategy to topically administer the permeants with a wide MW and lipophilicity range.


Assuntos
Sistemas de Liberação de Medicamentos , Lasers de Estado Sólido , Absorção Cutânea , Administração Cutânea , Ácido Aminolevulínico/farmacocinética , Aminoquinolinas/farmacocinética , Animais , Dextranos/farmacocinética , Fluoresceína/química , Fluoresceína-5-Isotiocianato/análogos & derivados , Fluoresceína-5-Isotiocianato/farmacocinética , Imiquimode , Camundongos Endogâmicos BALB C , Camundongos Nus , Peptídeos/farmacocinética , Infecções por Pseudomonas/prevenção & controle , Pseudomonas aeruginosa/isolamento & purificação , Pontos Quânticos , Pele/metabolismo , Pele/microbiologia , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus/isolamento & purificação , Suínos , Tretinoína/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA